June 18, 2018
FDA issues Safety Alert for compounded drugs containing triamcinolone, moxifloxacin
Editor's Note
The Food & Drug Administration (FDA) on June 14 issued a Safety Alert for compounded drugs containing triamcinolone and moxifloxacin by Guardian Pharmacy Services (Dallas, Texas).
At least 43 patients have reported adverse events after receiving eye injections of the compounded triamcinolone and moxifloxacin drug during cataract surgery.
The Guardian Pharmacy Services in Dallas is not affiliated with the national long-term care Guardian Pharmacy Services, LLC headquartered in Atlanta.
Free Daily News
- FDA: Surgical mesh mini-slings comparable to mid-urethral slings for stress urinary incontinence
- Federal regulations require written consent for pelvic exams at hospitals, medical schools
- Survey: More than half of ED nurses experienced violence in past month
- Heart transplant research proves out 24-hour organ preservation method
- Healthcare safety report: Outcomes improving, but workplace violence persists
- Annual CMS rules support underserved, under-resourced communities, promote value-based care
- Data resource details causes, health implications of sleep deprivation
- Medical error initiative from Joint Commission affiliate NQF targets preventable harm, “never events”
- EPA rule to limit dangerous emissions from medical sterilization plants
- Newly FDA-approved microsurgical system holds promise for training, new treatments
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging